Lidds AB
Develops a drug delivery platform for local, sustained-release oncology treatments.
LIDDS | ST
Overview
Corporate Details
- ISIN(s):
- SE0001958612
- LEI:
- 549300YYW8B918K7UN72
- Country:
- Sweden
- Address:
- Box 12040, 112 40 Stockholm
- Website:
- https://liddspharma.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Lidds AB is a pharmaceutical company that has developed the proprietary NanoZolid® drug delivery technology. This platform is designed for the local, controlled, and sustained release of drugs, aiming to enhance treatment efficacy at the target site while reducing systemic side effects. The technology involves injecting a drug formulation that solidifies into a depot, which releases its therapeutic payload over a prolonged period before being fully absorbed. The company applied this platform to build a pipeline of oncology candidates, including Liproca Depot for prostate cancer and Nanodotax. Lidds' strategy focused on reformulating existing drugs to lower development costs and has pursued partnerships to advance its technology.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Lidds AB and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Lidds AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Lidds AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-02-14 | Anders Månsson | Other | Buy | 100,000 | 140,000.00 SEK |
| 2023-02-10 | Matthew Lindon | Other | Buy | 71,428 | 99,999.20 SEK |
| 2023-02-09 | Daniel Lifveredson | Other | Other | 150,000 | 210,000.00 SEK |
| 2022-12-16 | Daniel Lifveredson | Other | Sell | 435,254 | 826,982.60 SEK |
| 2022-12-16 | Daniel Lifveredson | Other | Buy | 435,254 | 826,982.60 SEK |
| 2022-06-02 | Galba Holding AB | Other | Buy | 750,000 | 4,500,000.00 SEK |
| 2022-03-08 | Jan Törnell | Other | Buy | 5,000 | 32,500.00 SEK |
| 2021-06-30 | Nina Herne | Other | Other | 100,000 | 116,000.00 SEK |
| 2021-06-03 | Daniel Lifveredson | Other | Buy | 435,254 | 4,483,116.20 SEK |
| 2021-05-31 | Maria Forss | Other | Buy | 2,300 | 29,992.00 SEK |
